Ardsley Advisory Partners’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,000	Closed	-$350K	–	137
2018 Q1	$350K	Buy	+20,000	New	+$350K	0.05%	104
2017 Q4	–	Sell	-20,000	Closed	-$516K	–	126
2017 Q3	$516K	Buy	20,000 +5,000	+33%	+$129K	0.07%	82
2017 Q2	$407K	Buy	+15,000	New	+$407K	0.06%	84